A1 Refereed original research article in a scientific journal
Clinical and genetic characterisation of childhood-onset sensorineural hearing loss reveal associated phenotypes and enrichment of pathogenic founder mutations in the Finnish population
Authors: Kraatari-Tiri, Minna; Pykälainen, Tyrni; Pohjola, Pia; Häkli, Sanna; Rahikkala, Elisa
Publisher: Informa UK Limited
Publication year: 2024
Journal: International Journal of Audiology
Journal name in source: International Journal of Audiology
ISSN: 1499-2027
eISSN: 1708-8186
DOI: https://doi.org/10.1080/14992027.2024.2402840
Web address : https://doi.org/10.1080/14992027.2024.2402840
Objective
To examine the clinical and genetic characteristics of childhood-onset bilateral sensorineural hearing loss (SNHL) in Finland.
DesignRetrospective analysis.
Study sampleA total of 249 children younger than 18 years were diagnosed with bilateral SNHL in Oulu University Hospital, Finland, from 2017 to 2022.
ResultsPathogenic or likely pathogenic gene variants or chromosome abnormalities explaining SNHL were identified in 41% (N = 101/249) of children. Likely causative variants were more commonly identified in patients with severe SNHL than in those with moderate or mild SNHL. Our study identified likely causative gene variants in 24 different genes and six different likely causative chromosome abnormalities, demonstrating the genetic heterogeneity of SNHL. Population-enriched founder mutations were identified in the CABP2, CLRN1, MYO7A, SUCLA2, TMC1, and TWNK genes. A significant number of patients had associated phenotypes, including global developmental delay or intellectual disability (16%), language disorder (20%), ophthalmological abnormalities (16%), or malformations other than those involving the ear (10%).
ConclusionsSNHL is genetically and clinically heterogeneous. Pathogenic variants in GJB2 were the most common. Several population-enriched variants were identified as causing SNHL in the northern Finnish population. Associated medical phenotypes are common and should be taken into account in patients’ follow-up and treatment.
Funding information in the publication:
This study was funded by the Research Council of Finland [Grant Number 338446], Uolevi Mäki Foundation, and the Competetive State Research Financing of the Expert Responsibility Area of Oulu University Hospital.